Across tumor types, this shift is commonly driven by activation of the PI3K‐AKT–mTOR pathway, a key cell growth and survival pathway [55] that links cell proliferation and survival with glucose metabolism [56]. This evidence concerns the gene AKT1 and neoplasm.